“What is The Comparative Effectiveness of Targeted Therapy versus Immunotherapy in Terms of Overall Survival, Progression-free Survival, and Quality of Life For Patients With Metastatic Renal Cell Carcinoma? : A Systematic Review and Meta-Analysis ” (2025) Journal of Carcinogenesis, 24(10s), pp. 274–299. doi:10.64149/J.Carcinog.24.10s.274-299.